Press releases

PROENCY will provide real-world clinical data on the PROMUS™ Stent

"The turn that began last quarter continued this quarter, with strong adjusted earnings and record sales," said Jim Tobin, President and Chief Executive Officer

'Close the Gap' brings together advocates from cardiologists to coaches

A live webcast and replay of the February 6 session will be available.

NEJM article is entitled "A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications"

A live webcast and replay of the February 5 conference call will be available

CE Mark approvals are for COGNIS™ cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN™ implantable cardioverter defibrillator (ICD)

Ruling finds the NIR® stent, formerly sold by Company, infringed one claim of a patent owned by Johnson & Johnson

Divestitures are part of ongoing efforts to simplify operating model and restore profitable growth

Company retains ownership of Pain Management business